NCT07922850
Trial Treatment · University Hospital of North Norway
Nordland Hospital Trust, Bodø · University Hospital of North Norway, Tromsø
Registry updated 2026-11-06
2026-526317-29-00
Trial Treatment · Phase 2 · Akershus University Hospital
Akershus University Hospital, Lorenskog
Registry updated 2026-11-05
NCT07262619
Trial Treatment · Phase 1/2 · Eikon Therapeutics
Oslo University, Oslo
Registry updated 2026-10-30
NCT07284849
Trial Treatment · Phase 3 · Incyte Corporation
Helse Bergen HF, Bergen · Akershus University Hospital, Loerenskog · Oslo Universitetssykehus HF, Oslo
Registry updated 2026-10-30
NCT07255066
Trial Treatment · University of Edinburgh
Oslo University Hospital, Oslo
Registry updated 2026-10-20
NCT06885034
Trial Treatment · Phase 1/2 · GlaxoSmithKline
Lørenskog · Oslo · Stavanger
Registry updated 2026-10-19
2024-514541-11-00
Trial Treatment · Phase 2 · Sykehuset Telemark HF
Østfold Hospital Trust, Grålum · Akershus University Hospital, Lorenskog · Sykehuset Telemark HF, Skien · Sykehuset I Vestfold HF, Toensberg
Registry updated 2026-10-16
NCT06200831
Trial Treatment · Oslo University Hospital
Oslo University Hospital, Oslo
Registry updated 2026-10-16
NCT07872787
Trial Treatment · Helse Stavanger HF
Stavanger University Hospital, Stavanger
Registry updated 2026-10-14
NCT06333392
Trial Treatment · Vestre Viken Hospital Trust
Vestre Viken Health Trust, Bærum Hospital, Drammen · Østfold Hospital Health Trust, Grålum · Akershus University Hospital Health Trust, Lørenskog · Ullevål University Hospital Health Trust, Oslo
Registry updated 2026-09-04
NCT07158203
Trial Treatment · Fundacin Biomedica Galicia Sur
Clinical Effectiveness Research Group, Oslo
Registry updated 2026-09-03
NCT05253651
Trial Treatment · Phase 3 · Seagen, a wholly owned subsidiary of Pfizer
Helse Bergen HF, Bergen · Oslo University Hospital HF, Oslo
Registry updated 2026-07-22
NCT06907342
Trial Treatment · Phase 2 · St. Olavs Hospital
St. Olavs hospital HF, Trondheim
Registry updated 2026-07-20
NCT01762813
Research · Helse Stavanger HF
Stavanger University Hospital, Stavanger
Registry updated 2026-04-30
NCT07171554
Trial Treatment · Phase 2 · Oncosyne AS
Akershus University Hospital, Loerenskog
Registry updated 2026-04-30
NCT05732623
Research · San Raffaele University
Division of Cancer Medicine, Oslo University Hospital (OUS), Institute for Cancer Genetics and Informatics Norwegian Radium Hospital, Oslo
Registry updated 2026-04-24
NCT05855200
Trial Treatment · Phase 3 · GlaxoSmithKline
Helse Bergen HF, Bergen · Sorlandet Sykehus HF, Kristiansand S · Akershus University Hospital, Loerenskog · Oslo University Hospital HF, Oslo · Helse Stavanger HF, Stavanger
Registry updated 2026-01-23
NCT06983639
Trial Treatment · Sorlandet Hospital HF
Sørlandet sykehus HF, Arendal
Registry updated 2026-01-15
NCT07135115
Trial Treatment · Norwegian Institute of Public Health
Norwegian Institute of Public Health, Oslo
Registry updated 2025-09-03
NCT06307938
Research · Helse Nord-Trøndelag HF
Nord-Trøndelag Hospital Trust, Levanger
Registry updated 2025-04-30
NCT05056389
Trial Treatment · Phase 1 · Oslo University Hospital HF
Oslo University Hospital HF, Oslo
Registry updated 2024-11-14
NCT02292641
Trial Treatment · Imperial College London
Oslo University Hospital, Oslo
Registry updated 2024-10-17
NCT04680260
Trial Treatment · Phase 2 · Karen-Lise Garm Spindler
Oslo University Hospital HF, Oslo
Registry updated 2024-08-14
NCT05401318
Research · University Hospital, Akershus
Akershus University Hospital, Lørenskog
Registry updated 2024-08-06
NCT05883800
Trial Treatment · Haukeland University Hospital
Haukeland University Hospital, Bergen
Registry updated 2024-03-19
This page is not medical advice. Talk to your doctor before contacting a trial.